Literature DB >> 20716626

The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies.

J A Langendijk1, A Psyrri2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20716626     DOI： 10.1093/annonc/mdq439

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  22 in total

1.  Do patients with head and neck human papillomavirus-related carcinoma need a different treatment approach?

Authors:  Jon Cacicedo Fernandez de Bobadilla; Pedro Bilbao
Journal:  Int J Clin Oncol       Date:  2013-08-06       Impact factor: 3.402

2.  Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

Authors:  Mei Zhao; Daisuke Sano; Curtis R Pickering; Samar A Jasser; Ying C Henderson; Gary L Clayman; Erich M Sturgis; Thomas J Ow; Reuben Lotan; Thomas E Carey; Peter G Sacks; Jennifer R Grandis; David Sidransky; Nils Erik Heldin; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2011-08-25       Impact factor: 12.531

3.  Identification of HPV16-p16INK4a mediated methylation in oral potentially malignant disorder.

Authors:  Maria Rosa Buenahora; Gloria Inés Lafaurie; Sandra J Perdomo
Journal:  Epigenetics       Date:  2020-11-09       Impact factor: 4.528

4.  Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.

Authors:  Hisato Kawakami; Isamu Okamoto; Kyoichi Terao; Kazuko Sakai; Minoru Suzuki; Shinya Ueda; Kaoru Tanaka; Kiyoko Kuwata; Yume Morita; Koji Ono; Kazuto Nishio; Yasumasa Nishimura; Katsumi Doi; Kazuhiko Nakagawa
Journal:  Cancer Med       Date:  2013-10-27       Impact factor: 4.452

5.  Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC).

Authors:  S Skvortsov; J Dudás; P Eichberger; M Witsch-Baumgartner; J Loeffler-Ragg; C Pritz; V H Schartinger; H Maier; J Hall; P Debbage; H Riechelmann; P Lukas; I Skvortsova
Journal:  Br J Cancer       Date:  2014-05-01       Impact factor: 7.640

Review 6.  Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review.

Authors:  C Grønhøj Larsen; M Gyldenløve; D H Jensen; M H Therkildsen; K Kiss; B Norrild; L Konge; C von Buchwald
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

7.  Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.

Authors:  Elana J Fertig; Ana Markovic; Ludmila V Danilova; Daria A Gaykalova; Leslie Cope; Christine H Chung; Michael F Ochs; Joseph A Califano
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

8.  Prevalence of human papillomavirus types and variants and p16(INK4a) expression in head and neck squamous cells carcinomas in São Paulo, Brazil.

Authors:  Julio C Betiol; Laura Sichero; Henrique O de Olival Costa; Leandro L de Matos; Maria A Andreoli; Silvaneide Ferreira; Sheila F Faraj; Evandro S de Mello; João S Sobrinho; Lenine G Brandão; Claudio R Cernea; Marco A Kulcsar; Fabio R Pinto; Antonio J Gonçalves; Marcelo B Menezes; Leonardo Silva; Lia M Rossi; Rafaella A Lima Nunes; Lara Termini; Luisa L Villa
Journal:  Infect Agent Cancer       Date:  2016-05-04       Impact factor: 2.965

9.  Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck.

Authors:  Sarah A Flowers; Xin Zhou; Jing Wu; Yiwen Wang; Kepher Makambi; Bhaskar V Kallakury; Mark S Singer; Steven D Rosen; Bruce Davidson; Radoslav Goldman
Journal:  Oncotarget       Date:  2016-07-12

10.  Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.

Authors:  Kariem Sharaf; Axel Lechner; Stefan P Haider; Robert Wiebringhaus; Christoph Walz; Gisela Kranz; Martin Canis; Frank Haubner; Olivier Gires; Philipp Baumeister
Journal:  Curr Oncol       Date:  2021-07-19       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.